Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora .
作者信息
Martinez Sanz Paula, van Rees Dieke J, Matlung Hanke L, Tytgat Godelieve A M, Franke Katka
机构信息
Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands
Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands.
出版信息
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003983.
Abstract
摘要
相似文献
1
Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora .对莫拉就“在神经母细胞瘤治疗中，粒细胞集落刺激因子作为粒细胞-巨噬细胞集落刺激因子的合适替代物以增强地努图希单抗介导的中性粒细胞细胞毒性”的通信的回复。
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003983.
2
G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.粒细胞集落刺激因子（G-CSF）作为 GM-CSF 的替代选择，可增强神经母细胞瘤治疗中迪诺单抗介导的中性粒细胞细胞毒性。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002259.
3
Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz .关于马丁内斯·桑斯所著《粒细胞集落刺激因子作为粒细胞-巨噬细胞集落刺激因子的合适替代物以增强地努图希单抗在神经母细胞瘤治疗中介导的中性粒细胞细胞毒性》的通信
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003751.
4
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma.对于高危神经母细胞瘤，采用GM-CSF、G-CSF或不进行细胞因子治疗联合抗GD2免疫疗法。
Int J Cancer. 2024 Apr 15;154(8):1340-1364. doi: 10.1002/ijc.34815. Epub 2023 Dec 18.
5
Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.粒细胞-巨噬细胞集落刺激因子和粒细胞集落刺激因子增强抗GD2单克隆抗体220-51对人神经母细胞瘤的体内外抗肿瘤活性
Int J Mol Med. 1998 Oct;2(4):471-5. doi: 10.3892/ijmm.2.4.471.
6
Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.集落刺激因子增强髓样效应细胞对神经外胚层肿瘤细胞的细胞毒性。
Br J Haematol. 1993 Apr;83(4):545-53. doi: 10.1111/j.1365-2141.1993.tb04689.x.
7
Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.抗唾液酸神经节苷脂/粒细胞巨噬细胞集落刺激因子融合蛋白促进中性粒细胞抗体依赖性细胞毒性作用，并且增强效应细胞黏附及嗜天青颗粒胞吐作用依赖于FcγRII（CD32）和Mac-1（CD11b/CD18）。
Blood. 2002 Jun 1;99(11):4166-73. doi: 10.1182/blood.v99.11.4166.
8
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.替莫唑胺、伊立替康和 GM-CSF 联合治疗儿童难治性或复发性神经母细胞瘤：来自儿童肿瘤学组的报告。
J Clin Oncol. 2020 Jul 1;38(19):2160-2169. doi: 10.1200/JCO.20.00203. Epub 2020 Apr 28.
9
Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.在重症联合免疫缺陷小鼠淋巴瘤模型中，同时给予粒细胞集落刺激因子或粒细胞-单核细胞集落刺激因子可增强利妥昔单抗的生物活性。
Leuk Lymphoma. 2005 Dec;46(12):1775-84. doi: 10.1080/17402520500182329.
10
Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome.呼吸窘迫综合征早产儿支气管肺泡灌洗液中的粒细胞集落刺激因子、粒细胞巨噬细胞集落刺激因子和中性粒细胞
Biol Neonate. 2001 Aug;80(2):133-41. doi: 10.1159/000047132.
本文引用的文献
1
Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz .关于马丁内斯·桑斯所著《粒细胞集落刺激因子作为粒细胞-巨噬细胞集落刺激因子的合适替代物以增强地努图希单抗在神经母细胞瘤治疗中介导的中性粒细胞细胞毒性》的通信
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003751.
2
G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.粒细胞集落刺激因子（G-CSF）作为 GM-CSF 的替代选择，可增强神经母细胞瘤治疗中迪诺单抗介导的中性粒细胞细胞毒性。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002259.
3
G-CSF Is a Cancer Stem Cell-Specific Growth Factor-Letter.
Cancer Res. 2015 Sep 15;75(18):3991. doi: 10.1158/0008-5472.CAN-15-1445. Epub 2015 Sep 3.
4
G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.粒细胞集落刺激因子通过STAT3依赖性癌症干细胞激活促进神经母细胞瘤的致瘤性和转移。
Cancer Res. 2015 Jun 15;75(12):2566-79. doi: 10.1158/0008-5472.CAN-14-2946. Epub 2015 Apr 23.
5
G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.G-CSF 受体阳性神经母细胞瘤亚群在化疗耐药或复发的肿瘤中富集，且具有高度致瘤性。
Cancer Res. 2013 Jul 1;73(13):4134-46. doi: 10.1158/0008-5472.CAN-12-4056. Epub 2013 May 16.
6
Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients.粒细胞集落刺激因子改变神经母细胞瘤细胞的表型：对高危患者无病生存的影响。
J Pediatr Surg. 2008 May;43(5):837-42. doi: 10.1016/j.jpedsurg.2007.12.024.
7
Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells.一种嵌合抗神经节苷脂GD2抗体对人神经母细胞瘤细胞介导的细胞溶解作用。
Cancer Res. 1991 Jan 1;51(1):144-9.
Zotero 插件